Keywords
Overdiagnosis
Overtreatment
Health Care Quality
Delivery of Health Care
Diagnostic Tests
Routine
Behavior
drug prescriptions
How to Cite
Abstract
Context: In 2022, the Colombian Association of Endocrinology, Diabetes, and Metabolism (ACE) joined the Choosing Wisely initiative to prevent low-value medical practices.
Objective: To generate five evidence-based recommendations to decrease inappropriate clinical practices.
Methodology: A reviewing committee was established to identify "do not do" recommendations from ACE members. The most frequent recommendations were pre-selected, and a systematic literature search was conducted. Subsequently iterative rounds were conducted using the Delphi methodology to select the five recommendations that achieved the highest consensus among the panel of experts.
Results: Between October 2022 and April 2023, 117 active ACE members submitted a total of 211 recommendations. Of these, 109 were selected for further analysis. Subsequently, a Delphi panel identified five key recommendations, four of which addressed the excessive use of diagnostic tests, while the remaining one focused on therapeutic intervention.
Conclusions: To avoid unnecessary procedures, routine thyroid ultrasounds should not be performed on the general population or on hypothyroid individuals without changes in their physical examination. Requesting markers of bone turnover in patients with osteoporosis is also discouraged. Additionally, measuring basal insulin and/or post-glucose load in individuals who are overweight, obese, or have signs of insulin resistance is discouraged, along with indiscriminate measurements of vitamin D and unnecessary prescription of vitamin D supplements in the general population. The implementation of these recommendations could lead to a reduction in overdiagnosis and overtreatment of patients with endocrine conditions. This would help to improve resource management, quality of care, and clinical outcomes, benefiting both patients and the healthcare system.
References
Brownlee S, Chalkidou K, Doust J, Elshaug AG, Glasziou P, Heath I, et al. Evidence for overuse of medical services around the world. Lancet. 2017 Jul 8;390(10090):156-168. https://doi.org/10.1016/S0140-6736(16)32585-5
Born KB, Levinson W. Choosing Wisely campaigns globally: A shared approach to tackling the problem of overuse in healthcare. J Gen Fam Med. 2018 Dec 21;20(1):9-12. https://doi.org/10.1002/jgf2.225
Levinson W, Kallewaard M, Bhatia RS, Wolfson D, Shortt S, Kerr EA. Choosing Wisely International Working Group. Choosing Wisely: a growing international campaign. BMJ Qual Saf. 2015 Feb;24(2):167-74. https://doi.org/10.1136/bmjqs-2014-003821
Levinson W, Giraldo M. Choosing Wisely. Colomb. J. Anesthesiol 2022 Aug 3;50(4). https://doi.org/10.5554/22562087.e1047
Chant ED, Crawford M, Yang CW, Fisher ES, Morden NE, Ganguli I. Sources of Low-Value Care Received by Medicare Beneficiaries and Associated Spending Within US Health Systems. JAMA Netw Open. 2023;6(9):e2333505. https://doi.org/10.1001/jamanetworkopen.2023.33505
Ospina NS, Salloum RG, Maraka S, Brito JP. De-implementing low-value care in endocrinology. Endocrine 2021 Aug;73(2):292-300. https://doi.org/10.1007/s12020-021-02732-y
Jünger S, Payne SA, Brine J, Radbruch L, Brearley SG. Guidance on Conducting and REporting DElphi Studies (CREDES) in palliative care: Recommendations based on a methodological systematic review. Palliat Med. 2017 Sep;31(8):684-706. https://doi.org/10.1177/0269216317690685
Hunter KE, Webster AC, Clarke M, Page MJ, Libesman S, Godolphin PJ, et al. Development of a checklist of standard items for processing individual participant data from randomised trials for meta-analyses: Protocol for a modified e-Delphi study. PLoS One 2022;17(10 October):1–10. https://doi.org/10.1371/journal.pone.0275893
Boulkedid R, Abdoul H, Loustau M, Sibony O, Alberti C. Using and reporting the Delphi method for selecting healthcare quality indicators: a systematic review. PLoS One. 2011;6(6):e20476. https://doi.org/10.1371/journal.pone.0020476
Fernández-Ávila DG, Rojas MX, Rosselli D. El método Delphi en la investigación en reumatología: ¿lo estamos haciendo bien? Rev Colomb Reumatol [Internet]. 2020;27(3):177–89. https://doi.org/10.1016/j.rcreu.2019.04.001
Taylor E. We Agree, Don´t We? The Delphi Method for Health Environments Research. HERD. 2020 Jan;13(1):11-23. https://doi.org/10.1177/1937586719887709
Shang Z. Use of Delphi in health sciences research: A narrative review. Medicine (Baltimore). 2023 Feb 17;102(7):e32829. https://doi.org/10.1097/MD.0000000000032829
Jebb AT, Ng V, Tay L. A Review of Key Likert Scale Development Advances: 1995-2019. Front Psychol. 2021 May 4;12:637547. https://doi.org/10.3389/fpsyg.2021.637547
Davies L, Welch HG. Current thyroid cancer trends in the United States. JAMA Otolaryngol Head Neck Surg. 2014 Apr;140(4):317-22. https://doi.org/10.1001/jamaoto.2014.1
Ito Y, Uruno T, Nakano K, Takamura Y, Miya A, Kobayashi K, et al. An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid. Thyroid. 2003 Apr;13(4):381-7. https://doi.org/10.1089/105072503321669875
Ullmann TM, Papaleontiou M, Sosa JA. Current Controversies in Low-Risk Differentiated Thyroid Cancer: Reducing Overtreatment in an Era of Overdiagnosis. J Clin Endocrinol Metab. 2023 Jan 17;108(2):271-280. https://doi.org/10.1210/clinem/dgac646
Li M, Dal Maso L, Vaccarella S. Global trends in thyroid cancer incidence and the impact of overdiagnosis. Lancet Diabetes Endocrinol. 2020 Jun;8(6):468-470. https://doi.org/10.1016/S2213-8587(20)30115-7
Acosta GJ, Singh Ospina N, Brito JP. Overuse of thyroid ultrasound. Curr Opin Endocrinol Diabetes Obes. 2023 Oct 1;30(5):225-230. https://doi.org/10.1097/MED.0000000000000814
Ullmann TM, Papaleontiou M, Sosa JA. Current Controversies in Low-Risk Differentiated Thyroid Cancer: Reducing Overtreatment in an Era of Overdiagnosis. J Clin Endocrinol Metab. 2023 Jan 17;108(2):271-280. https://doi.org/10.1210/clinem/dgac646
Welch HG, Black WC. Overdiagnosis in cancer. J Natl Cancer Inst. 2010 May 5;102(9):605-13. https://doi.org/10.1093/jnci/djq099
Jensen CB, Saucke MC, Francis DO, Voils CI, Pitt SC. From Overdiagnosis to Overtreatment of Low-Risk Thyroid Cancer: A Thematic Analysis of Attitudes and Beliefs of Endocrinologists, Surgeons, and Patients. Thyroid. 2020 May;30(5):696-703. https://doi.org/10.1089/thy.2019.0587
Collée GE, van der Wilk BJ, van Lanschot JJB, Busschbach JJ, Timmermans L, Lagarde SM, et al. Interventions that Facilitate Shared Decision-Making in Cancers with Active Surveillance as Treatment Option: a Systematic Review of Literature. Curr Oncol Rep. 2020 Jul 28;22(10):101. https://doi.org/10.1007/s11912-020-00962-3
Nickel B, Brito JP, Moynihan R, Barratt A, Jordan S, McCaffery K. Patients´ experiences of diagnosis and management of papillary thyroid microcarcinoma: a qualitative study. BMC Cancer. 2018 Mar 2;18(1):242. https://doi.org/10.1186/s12885-018-4152-9
Agostino TA, Shuk E, Maloney EK, Zeuren R, Tuttle RM, Bylund CL. Treatment decision making in early-stage papillary thyroid cancer. Psychooncology. 2018 Jan;27(1):61-68. https://doi.org/10.1002/pon.4383
Sanabria A. Experience with Active Surveillance of Thyroid Low-Risk Carcinoma in a Developing Country. Thyroid. 2020 Jul;30(7):985-991. https://doi.org/10.1089/thy.2019.0522
Brito JP, Moon JH, Zeuren R, Kong SH, Kim YG, Iñiguez-Ariza NM, et al. Thyroid Cancer Treatment Choice: A Pilot Study of a Tool to Facilitate Conversations with Patients with Papillary Microcarcinomas Considering Treatment Options. Thyroid. 2018 Oct;28(10):1325-1331. https://doi.org/10.1089/thy.2018.0105
Wandurraga Sánchez EA, Marín Carrillo LF, Natera Melo AK, Giraldo CMG, Niño Prato F, Arenas Quintero HM, et al. Características clínicas, histopatológicas y terapéuticas del cáncer de tiroides en Colombia: serie de 1.096 pacientes. Rev Colomb Endocrinol Diabetes Metab. 2019;6(1):5–12. https://doi.org/10.53853/encr.6.1.462
Chen DW, Lang BHH, McLeod DSA, Newbold K, Haymart MR. Thyroid cancer. Lancet. 2023 May 6;401(10387):1531-1544. https://doi.org/10.1016/S0140-6736(23)00020-X
Alexander EK, Doherty GM, Barletta JA. Management of thyroid nodules. Lancet Diabetes Endocrinol. 2022 Jul;10(7):540-548. https://doi.org/10.1016/S2213-8587(22)00139-5
Edwards M, Brito JP, Salloum RG, Hoang J, Singh Ospina N. Implementation strategies to support ultrasound thyroid nodule risk stratification: A systematic review. Clin Endocrinol (Oxf). 2023 Oct;99(4):417-427. https://doi.org/10.1111/cen.14942
Szulc P, Naylor K, Hoyle NR, Eastell R, Leary ET. National Bone Health Alliance Bone Turnover Marker Project. Use of CTX-I and PINP as bone turnover markers: National Bone Health Alliance recommendations to standardize sample handling and patient preparation to reduce pre- analytical variability. Osteoporos Int. 2017 Sep;28(9):2541-2556. https://doi.org/10.1007/s00198-017-4082-4
Seibel MJ. Biochemical markers of bone turnover: part I: biochemistry and variability. Clin Biochem Rev. 2005 Nov;26(4):97-122.
Tian A, Ma J, Feng K, Liu Z, Chen L, Jia H, et al. Reference markers of bone turnover for prediction of fracture: a meta-analysis. J Orthop Surg Res. 2019 Feb 28;14(1):68. https://doi.org/10.1186/s13018-019-1100-6
Crandall CJ, Vasan S, LaCroix A, LeBoff MS, Cauley JA, Robbins JA, et al. Bone Turnover Markers Are Not Associated With Hip Fracture Risk: A Case- Control Study in the Womens Health Initiative. J Bone Miner Res. 2018 Jul;33(7):1199-1208. https://doi.org/10.1002/jbmr.3471
Lazarovici TS, Mesilaty-Gross S, Vered I, Pariente C, Kanety H, Givol N, et al. Serologic bone markers for predicting development of osteonecrosis of the jaw in patients receiving bisphosphonates. J Oral Maxillofac Surg. 2010 Sep;68(9):2241-7 https://doi.org/10.1016/j.joms.2010.05.043
Traboulsi-Garet B, Jorba-García A, Camps-Font O, Alves FA, Figueiredo R, Valmaseda-Castellón E. Is serum C-terminal telopeptide cross-link of type 1 collagen a reliable parameter for predicting the risk of medication-related osteonecrosis of the jaws? A systematic review and meta-analysis of diagnostic test accuracy. Clin Oral Investig. 2022 Mar;26(3):2371-2382. https://doi.org/10.1007/s00784-022-04383-3
Gregson CL, Armstrong DJ, Bowden J, Cooper C, Edwards J, Gittoes NJL, et al. UK clinical guideline for the prevention and treatment of osteoporosis. Arch Osteoporos. 2022 Apr 5;17(1):58. https://doi.org/10.1007/s11657-022-01061-5
Camacho PM, Petak SM, Binkley N, Diab DL, Eldeiry LS, Farooki A, et al. American Association of Clinical Endocrinologists/American College of Endocrinology Clinical Practice Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis— 2020 Update Executive Summary. Endocr Pract. 2020 May;26(Suppl 1):1-46. https://doi.org/10.4158/GL-2020-0524
Medina Orjuela A, Rosero Olarte Ó, Nel Rueda Plata P, Sánchez Escobar F, Chalem Choueka M, González Reyes MÁ, et al. II Consenso Colombiano para el Manejo de la Osteoporosis Posmenopáusica. Rev Colomb Reumatol. 2018;25(3):184–210. https://doi.org/10.1016/j.rcreu.2018.02.006
Pollak F, Araya V, Lanas A, Sapunar J, Arrese M, Aylwin CG lori, et al. II Consenso de la Sociedad Chilena de Endocrinología y Diabetes sobre resistencia a la insulina. Rev Med Chil. 2015;143(5):627–36. https://doi.org/10.4067/S0034-98872015000500012
Muniyappa R, Lee S, Chen H, Quon MJ. Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. Am J Physiol Endocrinol Metab. 2008 Jan;294(1):E15- 26. https://doi.org/10.1152/ajpendo.00645.2007
Gastaldelli A. Measuring and estimating insulin resistance in clinical and research settings. Obesity (Silver Spring). 2022 Aug;30(8):1549-1563. https://doi.org/10.1002/oby.23503
Borai A, Livingstone C, Kaddam I, Ferns G. Selection of the appropriate method for the assessment of insulin resistance. BMC Med Res Methodol. 2011 Nov 23;11:158. https://doi.org/10.1186/1471-2288-11-158
Takahashi K, Nakamura H, Sato H, Matsuda H, Takada K, Tsuji T. Four Plasma Glucose and Insulin Responses to a 75?g OGTT in Healthy Young Japanese Women. J Diabetes Res. 2018 Jan 30;2018:5742497. https://doi.org/10.1155/2018/5742497
Vaidya RA, Desai S, Moitra P, Salis S, Agashe S, Battalwar R, et al. Hyperinsulinemia: an early biomarker of metabolic dysfunction. Front Clin Diabetes Healthc. 2023 May 2;4:1159664. https://doi.org/10.3389/fcdhc.2023.1159664
Rosli N, Kwon HJ, Lim J, Yoon YA, Jeong JS. Measurement comparability of insulin assays using conventional immunoassay kits. J Clin Lab Anal. 2022 Jul;36(7):e24521. https://doi.org/10.1002/jcla.24521
Cryer PE, Axelrod L, Grossman AB, Heller SR, Montori VM, Seaquist ER, et al. Endocrine Society. Evaluation and management of adult hypoglycemic disorders: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2009 Mar;94(3):709-28. https://doi.org/10.1210/jc.2008-1410
Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009 Oct 20;120(16):1640-5. https://doi.org/10.1161/CIRCULATIONAHA.109.192644
Einhorn D, Reaven GM, Cobin RH, Ford E, Ganda OP, Handelsman Y, et al. American College of Endocrinology position statement on the insulin resistance syndrome. Endocr Pract. 2003 May-Jun;9(3):237-52. https://doi.org/10.4158/EP.9.S2.5
Thamattoor A. Race/ethnicity differences in vitamin D levels and impact on cardiovascular disease, bone health, and oral health. medRxiv [Internet]. 2021;25:2021.01.02.21249149. http://medrxiv.org/content/early/2021/01/04/2021.01.02.21249149.abstract
Kaya A. Vitamin D Seasonal Variation of Old Aged People in Konya Residantal Care in Turkey. Eurasian J Med Oncol. 2017;2(1):32–4. https://doi.org/10.14744/ejmo.2017.95867
Murguía-Romero M, Jiménez-Flores JR, Sigrist-Flores SC, Espinoza-Camacho MA, Jiménez-Morales M, Piña E, et al. Plasma triglyceride/HDL-cholesterol ratio, insulin resistance, and cardiometabolic risk in young adults. J Lipid Res. 2013 Oct;54(10):2795-9. https://doi.org/10.1194/jlr.M040584
Borrayo G, Basurto L, González-Escudero E, Diaz A, Vázquez A, Sánchez L, et al. TG/HDL-C ratio as cardio-metabolic biomarker even in normal weight women. Acta Endocrinol (Buchar). 2018 Apr-Jun;14(2):261-267. https://doi.org/10.4183/aeb.2018.261
Khaw KT, Stewart AW, Waayer D, Lawes CMM, Toop L, Camargo CA Jr, et al. Effect of monthly high-dose vitamin D supplementation on falls and non-vertebral fractures: secondary and post-hoc outcomes from the randomised, double-blind, placebo-controlled ViDA trial. Lancet Diabetes Endocrinol. 2017 Jun;5(6):438-447. https://doi.org/10.1016/S2213-8587(17)30103-1
LeBoff MS, Chou SH, Ratliff KA, Cook NR, Khurana B, Kim E, et al. Supplemental Vitamin D and Incident Fractures in Midlife and Older Adults. N Engl J Med. 2022 Jul 28;387(4):299-309. https://doi.org/10.1056/NEJMoa2202106
Scragg R, Khaw KT, Toop L, Sluyter J, Lawes CMM, Waayer D, et al. Monthly High-Dose Vitamin D Supplementation and Cancer Risk: A Post Hoc Analysis of the Vitamin D Assessment Randomized Clinical Trial. JAMA Oncol. 2018 Nov 1;4(11):e182178. https://doi.org/10.1001/jamaoncol.2018.2178
Manson JE, Cook NR, Lee IM, Christen W, Bassuk SS, Mora S, et al. VITAL Research Group. Vitamin D Supplements and Prevention of Cancer and Cardiovascular Disease. N Engl J Med. 2019 Jan 3;380(1):33-44. https://doi.org/10.1056/NEJMoa1809944
Pittas AG, Dawson-Hughes B, Sheehan P, Ware JH, Knowler WC, Aroda VR, et al. D2d Research Group. Vitamin D Supplementation and Prevention of Type 2 Diabetes. N Engl J Med. 2019 Aug 8;381(6):520-530. https://doi.org/10.1056/NEJMoa1900906
Bouillon R, Manousaki D, Rosen C, Trajanoska K, Rivadeneira F, Richards JB. The health effects of vitamin D supplementation: evidence from human studies. Nat Rev Endocrinol. 2022 Feb;18(2):96-110. https://doi.org/10.1038/s41574-021-00593-z
Bischoff-Ferrari HA, Vellas B, Rizzoli R, Kressig RW, da Silva JAP, Blauth M, et al. DO-HEALTH Research Group. Effect of Vitamin D Supplementation, Omega-3 Fatty Acid Supplementation, or a Strength-Training Exercise Program on Clinical Outcomes in Older Adults: The DO-HEALTH Randomized Clinical Trial. JAMA. 2020 Nov 10;324(18):1855-1868. https://doi.org/10.1001/jama.2020.16909 .
Smith H, Anderson F, Raphael H, Maslin P, Crozier S, Cooper C. Effect of annual intramuscular vitamin D on fracture risk in elderly men and women--a population-based, randomized, double-blind, placebo-controlled trial. Rheumatology (Oxford). 2007 Dec;46(12):1852-7. https://doi.org/10.1093/rheumatology/kem240
Sanders KM, Stuart AL, Williamson EJ, Simpson JA, Kotowicz MA, Young D, et al. Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial. JAMA. 2010 May 12;303(18):1815-22. https://doi.org/10.1001/jama.2010.594
Waterhouse M, Ebeling PR, McLeod DSA, English D, Romero BD, Baxter C, et al. The effect of monthly vitamin D supplementation on fractures: a tertiary outcome from the population-based, double-blind, randomised, placebo-controlled D-Health trial. Lancet Diabetes Endocrinol. 2023 May;11(5):324-332. https://doi.org/10.1016/S2213-8587(23)00063-3
Trivedi DP, Doll R, Khaw KT. Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial. BMJ. 2003 Mar 1;326(7387):469. https://doi.org/10.1136/bmj.326.7387.469
Lyons RA, Johansen A, Brophy S, Newcombe RG, Phillips CJ, Lervy B, et al. Preventing fractures among older people living in institutional care: a pragmatic randomised double blind placebo controlled trial of vitamin D supplementation. Osteoporos Int. 2007 Jun;18(6):811-8. https://doi.org/10.1007/s00198-006-0309-5
Lips P, Graafmans WC, Ooms ME, Bezemer PD, Bouter LM. Vitamin D supplementation and fracture incidence in elderly persons. A randomized, placebo-controlled clinical trial. Ann Intern Med. 1996 Feb 15;124(4):400-6. https://doi.org/10.7326/0003-4819-124-4-199602150-00003
Meyer HE, Smedshaug GB, Kvaavik E, Falch JA, Tverdal A, Pedersen JI. Can vitamin D supplementation reduce the risk of fracture in the elderly? A randomized controlled trial. J Bone Miner Res. 2002 Apr;17(4):709-15. https://doi.org/10.1359/jbmr.2002.17.4.709
Grant AM, Avenell A, Campbell MK, McDonald AM, MacLennan GS, McPherson GC, et al. RECORD Trial Group. Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium Or vitamin D, RECORD): a randomised placebo-controlled trial. Lancet. 2005 May 7-13;365(9471):1621-8. https://doi.org/10.1016/S0140-6736(05)63013-9
Chakhtoura M, Bacha DS, Gharios C, Ajjour S, Assaad M, Jabbour Y, et al. Vitamin D Supplementation and Fractures in Adults: A Systematic Umbrella Review of Meta-Analyses of Controlled Trials. J Clin Endocrinol Metab. 2022 Feb 17;107(3):882-898. https://doi.org/10.1210/clinem/dgab742
Waterhouse M, Sanguineti E, Baxter C, Duarte Romero B, McLeod DSA, English DR, et al. Vitamin D supplementation and risk of falling: outcomes from the randomized, placebo-controlled D-Health Trial. J Cachexia Sarcopenia Muscle. 2021 Dec;12(6):1428-1439. https://doi.org/10.1002/jcsm.12759
LeBoff MS, Murata EM, Cook NR, Cawthon P, Chou SH, Kotler G et al. VITamin D and OmegA-3 TriaL (VITAL): Effects of Vitamin D Supplements on Risk of Falls in the US Population. J Clin Endocrinol Metab. 2020 Sep 1;105(9):2929–38. https://doi.org/10.1210/clinem/dgaa311
Appel LJ, Michos ED, Mitchell CM, Blackford AL, Sternberg AL, Miller ER 3rd, et al. STURDY Collaborative Research Group. The Effects of Four Doses of Vitamin D Supplements on Falls in Older Adults : A Response-Adaptive, Randomized Clinical Trial. Ann Intern Med. 2021 Feb;174(2):145-156. https://doi.org/10.7326/M20-3812
Chatterjee R, Fuss P, Vickery EM, LeBlanc ES, Sheehan PR, Lewis MR, et al. D2d Research Group. Vitamin D Supplementation for Prevention of Cancer: The D2d Cancer Outcomes (D2dCA) Ancillary Study. J Clin Endocrinol Metab. 2021 Aug 18;106(9):2767-2778. https://doi.org/10.1210/clinem/dgab153
Virtanen JK, Nurmi T, Aro A, Bertone-Johnson ER, Hyppönen E, Kröger H, et al. Vitamin D supplementation and prevention of cardiovascular disease and cancer in the Finnish Vitamin D Trial: a randomized controlled trial. Am J Clin Nutr. 2022 May 1;115(5):1300-1310. https://doi.org/10.1093/ajcn/nqab419
Neale RE, Baxter C, Romero BD, McLeod DSA, English DR, Armstrong BK, et al. The D-Health Trial: a randomised controlled trial of the effect of vitamin D on mortality. Lancet Diabetes Endocrinol. 2022 Feb;10(2):120-128. https://doi.org/10.1016/S2213-8587(21)00345-4
Thompson B, Waterhouse M, English DR, McLeod DS, Armstrong BK, Baxter C, et al. Vitamin D supplementation and major cardiovascular events: D-Health randomised controlled trial. BMJ. 2023 Jun 28;381:e075230. https://doi.org/10.1136/bmj-2023-075230
Jorde R, Sollid ST, Svartberg J, Schirmer H, Joakimsen RM, Njølstad I, et al. Vitamin D 20,000 IU per Week for Five Years Does Not Prevent Progression From Prediabetes to Diabetes. J Clin Endocrinol Metab. 2016 Apr;101(4):1647-55. https://doi.org/10.1210/jc.2015-4013
Pittas AG, Kawahara T, Jorde R, Dawson-Hughes B, Vickery EM, Angellotti E, et al. Vitamin D and Risk for Type 2 Diabetes in People With Prediabetes: A Systematic Review and Meta-analysis of Individual Participant Data From 3 Randomized Clinical Trials. Ann Intern Med. 2023 Mar;176(3):355-363. https://doi.org/10.7326/M22-3018
Kawahara T, Suzuki G, Mizuno S, Inazu T, Kasagi F, Kawahara C, et al. Effect of active vitamin D treatment on development of type 2 diabetes: DPVD randomised controlled trial in Japanese population. BMJ. 2022 May 25;377:e066222. https://doi.org/10.1136/bmj-2021-066222
Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002 Feb 7;346(6):393-403. https://doi.org/10.1056/NEJMoa012512
Forno E, Bacharier LB, Phipatanakul W, Guilbert TW, Cabana MD, Ross K, et al. Effect of Vitamin D3 Supplementation on Severe Asthma Exacerbations in Children With Asthma and Low Vitamin D Levels: The VDKA Randomized Clinical Trial. JAMA. 2020 Aug 25;324(8):752-760. https://doi.org/10.1001/jama.2020.12384
Castro M, King TS, Kunselman SJ, Cabana MD, Denlinger L, Holguin F, et al. National Heart, Lung, and Blood Institute’s AsthmaNet. Effect of vitamin D3 on asthma treatment failures in adults with symptomatic asthma and lower vitamin D levels: the VIDA randomized clinical trial. JAMA. 2014 May;311(20):2083-91. https://doi.org/10.1001/jama.2014.5052
Jolliffe DA, Camargo CA Jr, Sluyter JD, Aglipay M, Aloia JF, Ganmaa D, et al. Vitamin D supplementation to prevent acute respiratory infections: a systematic review and meta-analysis of aggregate data from randomised controlled trials. Lancet Diabetes Endocrinol. 2021 May;9(5):276-292. https://doi.org/10.1016/S2213-8587(21)00051-6
Pham H, Waterhouse M, Baxter C, Duarte Romero B, McLeod DSA, Armstrong BK, et al. The effect of vitamin D supplementation on acute respiratory tract infection in older Australian adults: an analysis of data from the D-Health Trial. Lancet Diabetes Endocrinol. 2021 Feb;9(2):69-81. https://doi.org/10.1016/S2213-8587(20)30380-6
Jolliffe DA, Holt H, Greenig M, Talaei M, Perdek N, Pfeffer P, et al. Effect of a test-and-treat approach to vitamin D supplementation on risk of all cause acute respiratory tract infection and covid-19: phase 3 randomised controlled trial (CORONAVIT). BMJ. 2022 Sep 7;378:e071230. https://doi.org/10.1136/bmj-2022-071230 .
Brunvoll SH, Nygaard AB, Ellingjord-Dale M, Holland P, Istre MS, Kalleberg KT, et al. Prevention of covid-19 and other acute respiratory infections with cod liver oil supplementation, a low dose vitamin D supplement: quadruple blinded, randomised placebo controlled trial. BMJ. 2022 Sep 7;378:e071245. https://doi.org/10.1136/bmj-2022-071245
Hahn J, Cook NR, Alexander EK, Friedman S, Walter J, Bubes V, et al. Vitamin D and marine omega 3 fatty acid supplementation and incident autoimmune disease: VITAL randomized controlled trial. BMJ. 2022 Jan 26;376:e066452. https://doi.org/10.1136/bmj-2021-066452
Bezerra Espinola MS, Bilotta G, Aragona C. Positive effect of a new supplementation of vitamin D3 with myo-inositol, folic acid and melatonin on IVF outcomes: a prospective randomized and controlled pilot study. Gynecol Endocrinol. 2021 Mar;37(3):251-254. https://doi.org/10.1080/09513590.2020.1760820
Cummings SR, Rosen C. VITAL Findings - A Decisive Verdict on Vitamin D Supplementation. N Engl J Med. 2022 Jul 28;387(4):368-370. https://doi.org/10.1056/NEJMe2205993
Builes Barrera CA. Comportamiento de los niveles de 25 hidroxi-vitamina D, calcio y paratohormona en una población de 20 a 60 años en Medellín- Colombia. Rev Colomb Endocrinol Diabetes Metab. 2017 Oct 9;4(3):14–9. https://doi.org/10.53853/encr.4.3.131
Giustina A, Bouillon R, Binkley N, Sempos C, Adler RA, Bollerslev J, et al. Controversies in Vitamin D: A Statement From the Third Internationa Conference. JBMR Plus. 2020 Nov 10;4(12):e10417. https://doi.org/10.1002/jbm4.10417
Agudelo-Zapata Y, Maldonado-Acosta LM, Sandoval-Alzate HF, Poveda NE, Garcés MF, Cortés-Vásquez JA, et al. Serum 25-hydroxyvitamin D levels throughout pregnancy: A longitudinal study in healthy and preeclamptic pregnant women. Endocr Connect. 2018 May;7(5):698-707. https://doi.org/10.1530/EC-18-0055
Guagnano MT, D’Ardes D, Di Giovanni P, Rossi I, Boccatonda A, Bucci M, et al. Gender, Obesity, Fat Distribution and 25-Hydroxyvitamin D. Medicina (B Aires) [Internet]. 2023 Jun 11;59(6):1123. https://doi.org/10.3390/medicina59061123
Bikle DD, Schwartz J. Vitamin D binding protein, total and free Vitamin D levels in different physiological and pathophysiological conditions. Front Endocrinol (Lausanne). 2019;10(MAY):1–12. https://doi.org/10.3389/fendo.2019.00317
Bouillon R, Schuit F, Antonio L, Rastinejad F. Vitamin D Binding Protein: A Historic Overview. Front Endocrinol (Lausanne). 2020 Jan 10;10:910. https://doi.org/10.3389/fendo.2019.00910
Alonso N, Zelzer S, Eibinger G, Herrmann M. Vitamin D Metabolites: Analytical Challenges and Clinical Relevance. Calcif Tissue Int. 2023 Feb;112(2):158-177. https://doi.org/10.1007/s00223-022-00961-5
Haris A, Lam YPY, Wootton CA, Theisen A, Marzullo BP, Schorr P, et al. Differentiation of Dihydroxylated Vitamin D 3 Isomers Using Tandem Mass Spectrometry. J Am Soc Mass Spectrom. 2022 Jun 1;33(6):1022-1030. https://doi.org/10.1021/jasms.2c00085
Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011 Jul;96(7):1911-30. https://doi.org/10.1210/jc.2011-0385
Vásquez-Awad D, Alberto Cano-Gutiérrez C, Gómez-Ortiz A, Ángel González M, Guzmán-Moreno R, Ignacio Martínez-Reyes J, et al. Vitamina D. Consenso colombiano de expertos. Med. 2017;39(2):120–5498.
Dora JM, Biscolla RPM, Caldas G, Cerutti J, Graf H, Hoff AO, et al. Choosing Wisely for Thyroid Conditions: Recommendations of the Thyroid Department of the Brazilian Society of Endocrinology and Metabolism. Arch Endocrinol Metab. 2021 Nov 1;65(2):248-252. https://doi.org/10.20945/2359-3997000000323
La Vecchia C, Malvezzi M, Bosetti C, Garavello W, Bertuccio P, Levi F, et al. Thyroid cancer mortality and incidence: a global overview. Int J Cancer. 2015 May 1;136(9):2187-95. https://doi.org/10.1002/ijc.29251
Sierra MS, Soerjomataram I, Forman D. Thyroid cancer burden in Central and South America. Cancer Epidemiol. 2016 Sep;44 Suppl 1:S150-S157. https://doi.org/10.1016/j.canep.2016.07.017
Uricoechea HV, Chaparro JH, Cabrera IM DV. Epidemiologi?a del ca?ncer de tiroides. Ana?lisis de resultados en Sudame?rica y Colombia. Rev Med [Internet]. 2015;37(2):140–63.
Smulever A, Pitoia F. Active surveillance in papillary thyroid carcinoma: not easily accepted but possible in Latin America. Arch Endocrinol Metab. 2019 Sep 2;63(5):462-469. https://doi.org/10.20945/2359-3997000000168
Rosario PW, Ward LS, Graf H, Vaisman F, Mourão GF, Vaisman M. Thyroid nodules ? 1 cm and papillary thyroid microcarcinomas: Brazilian experts opinion. Arch Endocrinol Metab. 2019 Sep 2;63(5):456-461. https://doi.org/10.20945/2359-3997000000166
Sanabria A, Kowalski LP, Shah JP, Nixon IJ, Angelos P, Williams MD, et al. Growing incidence of thyroid carcinoma in recent years: Factors underlying overdiagnosis. Head Neck. 2018 Apr;40(4):855-866. https://doi.org/10.1002/hed.25029
Vargas-Uricoechea H, Casas-Figueroa LÁ. An Epidemiologic Analysis of Diabetes in Colombia. Ann Glob Health. 2015 Nov-Dec;81(6):742-53. https://doi.org/10.1016/j.aogh.2015.11.001
Anillo-Arrieta LA, Flórez-Lozano KC, Tuesca-Molina R, Acosta-Vergara T, Rodríguez-Acosta S, Aschner P, et al. Glycemic status and health-related quality of life (HRQOL) in populations at risk of diabetes in two Latin American cities. Qual Life Res. 2023 Aug;32(8):2361-2373. https://doi.org/10.1007/s11136-023-03398-x
Encuesta Nacional de la Situación Nutricional en Colombia. (2015). Disponible en: https://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/VS/ED/CFI/documento-metodologico-ensin-2015.pdf
Palacios-Bayona, KL. ‘Optimizing TSH Testing: Minimizing Overdiagnosis and Unnecessary Interventions’. Hypothyroidism - Causes, Screening and Therapeutic Approaches [Working Title], IntechOpen, 26 Apr. 2024. https://doi.org/10.5772/intechopen.1005108
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright (c) 2024 Revista Colombiana de Endocrinología, Diabetes & Metabolismo